Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop
tumor cells from dividing so they stop growing or die.
PURPOSE: This phase II trial is studying how well docetaxel works in treating patients with
recurrent or persistent endometrial carcinoma (cancer).